The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Rakesh Jain, MD, MPH,1 Andrew Penn, MS, PMHNP-BC,2 Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, FAAN,3 Madhukar H. Trivedi, MD,4 Alejandro G. Hughes, MPH,5 Noah S. Webb, PhD,5 Kanika Ballani, PharmD, MBA,6 Michael J. Doane, PhD,6 Hemangi R. Panchmatia, MSc,6 Andrew J. Cutler, MD7,8
1Department of Psychiatry, Texas Tech University School of Medicine-Permian Basin, Midland, TX, USA; 2School of Nursing, University of California San Francisco, San Francisco, CA, USA; 3Department of Psychiatry, University of Illinois Chicago, Chicago, IL, USA; 4Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA; 5Optum, Inc., Eden Prairie, MN, USA; 6Alkermes, Inc., Waltham, MA, USA; 7Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA; 8Neuroscience Education Institute, Lakewood Ranch, FL, USA
